- Home
- DUO vs CSCI Comparison
DUO vs CSCI Comparison
Compare DUO & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- CSCI
- Stock Information
- Founded
- DUO 2011
- CSCI 1990
- Country
- DUO China
- CSCI Canada
- Employees
- DUO N/A
- CSCI N/A
- Industry
- DUO Real Estate
- CSCI
- Sector
- DUO Finance
- CSCI
- Exchange
- DUO Nasdaq
- CSCI NYSE
- Market Cap
- DUO 11.4M
- CSCI 10.5M
- IPO Year
- DUO 2019
- CSCI 1996
- Fundamental
- Price
- DUO $2.18
- CSCI $3.37
- Analyst Decision
- DUO
- CSCI
- Analyst Count
- DUO 0
- CSCI 0
- Target Price
- DUO N/A
- CSCI N/A
- AVG Volume (30 Days)
- DUO 178.9K
- CSCI 2.1K
- Earning Date
- DUO 07-07-2025
- CSCI 08-12-2025
- Dividend Yield
- DUO N/A
- CSCI N/A
- EPS Growth
- DUO N/A
- CSCI N/A
- EPS
- DUO 7.57
- CSCI N/A
- Revenue
- DUO $46,458,330.00
- CSCI $9,030,000.00
- Revenue This Year
- DUO N/A
- CSCI N/A
- Revenue Next Year
- DUO N/A
- CSCI N/A
- P/E Ratio
- DUO $0.30
- CSCI N/A
- Revenue Growth
- DUO 19.00
- CSCI 36.51
- 52 Week Low
- DUO $2.13
- CSCI $1.96
- 52 Week High
- DUO $74.72
- CSCI $7.54
- Technical
- Relative Strength Index (RSI)
- DUO 29.52
- CSCI N/A
- Support Level
- DUO $2.33
- CSCI N/A
- Resistance Level
- DUO $2.49
- CSCI N/A
- Average True Range (ATR)
- DUO 0.23
- CSCI 0.00
- MACD
- DUO -0.00
- CSCI 0.00
- Stochastic Oscillator
- DUO 3.76
- CSCI 0.00
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.